Dual 5-LO/COX inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

BW 755C

Item No. 15490

Technical Information
Formal Name
4,5-dihydro-1-[3-(trifluoromethyl)phenyl]-1H-pyrazol-3-amine
CAS Number
66000-40-6
Molecular Formula
C10H10F3N3
Formula Weight
Purity
≥95%
Formulation
A crystalline solid
DMF: 25 mg/mlDMSO: 30 mg/mlEthanol: 30 mg/mlEthanol:PBS(pH 7.2) (1:1): 0.5 mg/ml
λmax
286 nm
SMILES
NC(CC1)=NN1C2=CC=CC(C(F)(F)F)=C2
InChi Code
InChI=1S/C10H10F3N3/c11-10(12,13)7-2-1-3-8(6-7)16-5-4-9(14)15-16/h1-3,6H,4-5H2,(H2,14,15)
InChi Key
CPXGGWXJNQSFEP-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Lipid Resource Center
    Discover Products & Resources for Lipid Research
    • High-purity lipid standards
    • Lipid roles in biology
    • Lipids in health & disease
    • Lipids for pharmaceutical development
    • Protocols, advice, & resources
    EXPLORE NOW
    Product Description

    BW 755C is a dual inhibitor of 5-lipoxygenase (5-LO) and cyclooxygenase (COX) pathways, inhibiting 5-LO, COX-1, and COX-2 (IC50s = 0.75 μM, 0.65 μg/ml, and 1.2 μg/ml, respectively).1,2,3 It may also inhibit other LO pathways in vivo.4 Through these actions, BW 755C diminishes inflammation.5,6

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Aizawa, Y., Kanai, T., Hasegawa, K., et alStudies on hindered phenols and analogues. 2. 1,3-Benzoxathioles having SRS-A inhibiting activity. J. Med. Chem. 33(5), 1491-1496 (1990).

    2. Hlasta, D.J., Casey, F.B., Ferguson, E.W., et al5-Lipoxygenase inhibitors: The synthesis and structure-activity relationships of a series of 1-phenyl-3-pyrazolidinones. J. Med. Chem. 34(5), 1560-1570 (1991).

    3. Mitchell, J.A., Akarasereenont, P., Thiemermann, C., et alSelectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. USA 90(24), 11693-11697 (1993).

    4. Tanaka, N., Espey, L.L., Kawano, T., et alComparison of inhibitory actions of indomethacin and epostane on ovulation in rats. Am. J. Physiol. 260, E170-E174 (1991).

    5. Higgs, G.A., Flower, R.J., and Vane, J.R. A new approach to anti-inflammatory drugs. Biochem. Pharmacol. 28, 1959-1961 (1979).

    6. Calhoun, W., Yu, J., Sung, A., et alPharmacologic modulation of D-49 phospholipase A2-induced paw edema in the mouse. Agents Actions 27, 418-421 (1989).